Analyst: This Penny Stock Could Triple

Euro Pacific Capital thinks upbeat data could snag COCP a large-pharma partner -- or suitor

Jul 17, 2018 at 11:12 AM
facebook X logo linkedin


Biotech stock Cocrystal Pharma Inc (NASDAQ:COCP) is higher this morning, thanks to some bullish attention from analysts. Specifically, Euro Pacific Capital initiated coverage of COCP with a "buy" rating and $14 price target -- representing expected upside of more than 200% to the security's close of $4.34 yesterday. At last check, COCP shares have jumped 4.4% to trade at $4.53.

Digging deeper, the brokerage firm said the market opportunity for hepatitis C infection (HCV) products is "one of the biggest in pharma," and expressed confidence in Cocrystal's management -- in particular, board chairman Dr. Raymond F. Schinazi, co-founder of two pharma companies that were ultimately scooped up by Gilead Sciences (GILD) and Merck (MRK). What's more, Euro Capital thinks positive data "could cause larger pharma to either partner for the development of CC-31244 or to acquire COCP outright."

Cocrystal Pharma stock has already surged 181% since touching a record low of $1.61 in early May. Now, the shares are on pace to retake their 160-day moving average for the first time in 2018. This trendline served as support for COCP in late 2017, and could resume its role as a foothold if today's rally holds.

cocp stock daily price chart on july 17

 

*SPONSORED CONTENT*

How to collect 1 dividend check every day for LIFE

Did you know you could collect 1 dividend check every day the market is open? You could also do it starting with just $605! For me, I'm collecting 70 dividend checks every quarter…which averages around 1.1 dividend checks every business day. There's no trading behind this... no penny stocks or high-risk investments. All you do is buy and hold and you're set. There's no set up required either. If you start buying the dividend stocks I show you today... you could collect 1 dividend per day starting as early as this week. Click here for all the details.

*SPONSORED CONTENT*